Log in
Enquire now

List of Biomed Valley Discoveries patents

List of Biomed Valley Discoveries patents
List of Restor3d patents
List of University of Hawaii Press patents
List of Telia Company patents
List of companies in NewVenture Partners's investment portfolio
List of patents in the Enzyme kinetics industry
Patents where
Current Assignee
Name
is
Biomed Valley DiscoveriesBiomed Valley Discoveries
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 11007184 Cancer treatments using combinations of type 2 MEK and ERK inhibitors

Patent 11007184 was granted and assigned to Biomed Valley Discoveries on May, 2021 by the United States Patent and Trademark Office.

Biomed Valley Discoveries
Biomed Valley Discoveries
Biomed Valley Discoveries
Biomed Valley Discoveries
United States Patent and Trademark Office
United States Patent and Trademark Office
11007184
May 18, 2021
‌
US Patent 9861621 LPT-723 and immune checkpoint inhibitor combinations and methods of treatment

Patent 9861621 was granted and assigned to Biomed Valley Discoveries on January, 2018 by the United States Patent and Trademark Office.

Biomed Valley Discoveries
Biomed Valley Discoveries
Biomed Valley Discoveries
Biomed Valley Discoveries
United States Patent and Trademark Office
United States Patent and Trademark Office
9861621
January 9, 2018
‌
US Patent 11033537 LPT-723 and immune checkpoint inhibitor combinations and methods of treatment

Patent 11033537 was granted and assigned to Biomed Valley Discoveries on June, 2021 by the United States Patent and Trademark Office.

Biomed Valley Discoveries
Biomed Valley Discoveries
Biomed Valley Discoveries
Biomed Valley Discoveries
United States Patent and Trademark Office
United States Patent and Trademark Office
11033537
June 15, 2021
‌
US Patent 10881646 Methods and compositions for treating non-ERK MAPK pathway inhibitor-resistant cancers

Patent 10881646 was granted and assigned to Biomed Valley Discoveries on January, 2021 by the United States Patent and Trademark Office.

Biomed Valley Discoveries
Biomed Valley Discoveries
Biomed Valley Discoveries
Biomed Valley Discoveries
United States Patent and Trademark Office
United States Patent and Trademark Office
10881646
January 5, 2021
‌
US Patent 10485796 LPT-723 and immune checkpoint inhibitor combinations and methods of treatment

Patent 10485796 was granted and assigned to Biomed Valley Discoveries on November, 2019 by the United States Patent and Trademark Office.

Biomed Valley Discoveries
Biomed Valley Discoveries
Biomed Valley Discoveries
Biomed Valley Discoveries
United States Patent and Trademark Office
United States Patent and Trademark Office
10485796
November 26, 2019
‌
US Patent 11007183 Cancer treatments using combinations of PI3K/Akt pathway and ERK inhibitors

Patent 11007183 was granted and assigned to Biomed Valley Discoveries on May, 2021 by the United States Patent and Trademark Office.

Biomed Valley Discoveries
Biomed Valley Discoveries
Biomed Valley Discoveries
Biomed Valley Discoveries
United States Patent and Trademark Office
United States Patent and Trademark Office
11007183
May 18, 2021
‌
US Patent 11013743 Cancer treatments using combinations of CDK and ERK inhibitors

Patent 11013743 was granted and assigned to Biomed Valley Discoveries on May, 2021 by the United States Patent and Trademark Office.

Biomed Valley Discoveries
Biomed Valley Discoveries
Biomed Valley Discoveries
Biomed Valley Discoveries
United States Patent and Trademark Office
United States Patent and Trademark Office
11013743
May 25, 2021
‌
US Patent 11135225 Cancer treatments using combinations of CDK and ERK inhibitors

Patent 11135225 was granted and assigned to Biomed Valley Discoveries on October, 2021 by the United States Patent and Trademark Office.

Biomed Valley Discoveries
Biomed Valley Discoveries
Biomed Valley Discoveries
Biomed Valley Discoveries
United States Patent and Trademark Office
United States Patent and Trademark Office
11135225
October 5, 2021
‌
US Patent 10716782 LPT-723 and immune checkpoint inhibitor combinations and methods of treatment

Biomed Valley Discoveries
Biomed Valley Discoveries
Biomed Valley Discoveries
Biomed Valley Discoveries
United States Patent and Trademark Office
United States Patent and Trademark Office
10716782
July 21, 2020
‌
US Patent 11246859 Methods and compositions for treating non-ERK MAPK pathway inhibitor-resistant cancers

Patent 11246859 was granted and assigned to Biomed Valley Discoveries on February, 2022 by the United States Patent and Trademark Office.

Biomed Valley Discoveries
Biomed Valley Discoveries
Biomed Valley Discoveries
Biomed Valley Discoveries
United States Patent and Trademark Office
United States Patent and Trademark Office
11246859
February 15, 2022
‌
US Patent 9951041 Crystalline C

Patent 9951041 was granted and assigned to Biomed Valley Discoveries on April, 2018 by the United States Patent and Trademark Office.

Biomed Valley Discoveries
Biomed Valley Discoveries
Biomed Valley Discoveries
Biomed Valley Discoveries
United States Patent and Trademark Office
United States Patent and Trademark Office
9951041
April 24, 2018
‌
US Patent 9757424 Compositions and methods of treating gliomas

Patent 9757424 was granted and assigned to Biomed Valley Discoveries on September, 2017 by the United States Patent and Trademark Office.

Biomed Valley Discoveries
Biomed Valley Discoveries
Biomed Valley Discoveries
Biomed Valley Discoveries
United States Patent and Trademark Office
United States Patent and Trademark Office
9757424
September 12, 2017
‌
US Patent 10668055 Cancer treatment using combinations of ERK and RAF inhibitors

Patent 10668055 was granted and assigned to Biomed Valley Discoveries on June, 2020 by the United States Patent and Trademark Office.

Biomed Valley Discoveries
Biomed Valley Discoveries
Biomed Valley Discoveries
Biomed Valley Discoveries
United States Patent and Trademark Office
United States Patent and Trademark Office
10668055
June 2, 2020
‌
US Patent 11679112 Cancer treatments using combinations of CDK and ERK inhibitors

Biomed Valley Discoveries
Biomed Valley Discoveries
Biomed Valley Discoveries
Biomed Valley Discoveries
United States Patent and Trademark Office
United States Patent and Trademark Office
11679112
June 20, 2023
‌
US Patent 12076324 Cancer treatments using combinations of CDK and ERK inhibitors

Patent 12076324 was granted and assigned to Biomed Valley Discoveries on September, 2024 by the United States Patent and Trademark Office.

Biomed Valley Discoveries
Biomed Valley Discoveries
Biomed Valley Discoveries
Biomed Valley Discoveries
United States Patent and Trademark Office
United States Patent and Trademark Office
12076324
September 3, 2024
15 results
0 selected
15 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us